Together with our colleagues from Amsterdam and Leiden, we have taken a closer look into the antiinfective and immunomodulating effects our in-house […]
We announce funding for our breakthrough anti-microbial research program by the Netherlands NACTAR program from the Netherlands organization for Scientific Research (NWO). […]
We expand business to ophthalmologyTübingen, Germany, February 2014. Synovo, a company focused on drug discovery and preclinical development, today announced the strategic […]